CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas ; volume:16 ; number:1 ; day:3 ; month:6 ; year:2016 ; pages:1-12 ; date:12.2016
BMC ophthalmology ; 16, Heft 1 (3.6.2016), 1-12, 12.2016
- Urheber
-
Lüke, Julia
- Beteiligte Personen und Organisationen
-
Vukoja, Vlatka
Brandenbusch, Tim
Nassar, Khaled
Rohrbach, Jens Martin
Grisanti, Salvatore
Lüke, Matthias
Tura, Aysegül
SpringerLink (Online service)
- DOI
-
10.1186/s12886-016-0222-4
- URN
-
urn:nbn:de:1111-201606047420
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lüke, Julia
- Vukoja, Vlatka
- Brandenbusch, Tim
- Nassar, Khaled
- Rohrbach, Jens Martin
- Grisanti, Salvatore
- Lüke, Matthias
- Tura, Aysegül
- SpringerLink (Online service)
Ähnliche Objekte (12)
Revealing the structural microenvironment of high metastatic risk uveal melanomas following decellularisation
Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas
Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma
Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas
Non-metastatic causes of multiple pulmonary nodules
Novel treatment paradigms for metastatic uveal melanoma
A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas
Mutational analysis in patients with uveal melanomas
Treatment options of metastatic and nonmetastatic VIPoma: a review
Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis
Revealing the structural microenvironment of high metastatic risk uveal melanomas following decellularisation
Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas
Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma
Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas
Non-metastatic causes of multiple pulmonary nodules
Novel treatment paradigms for metastatic uveal melanoma
A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas
Mutational analysis in patients with uveal melanomas
Treatment options of metastatic and nonmetastatic VIPoma: a review
Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis
Revealing the structural microenvironment of high metastatic risk uveal melanomas following decellularisation
Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas
Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma
Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas
Non-metastatic causes of multiple pulmonary nodules
Novel treatment paradigms for metastatic uveal melanoma
A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas
Mutational analysis in patients with uveal melanomas
Treatment options of metastatic and nonmetastatic VIPoma: a review
Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer
Pembrolizumab as first-line treatment for metastatic uveal melanoma